Recent studies in mouse AD models indicate that the activation of the Wnt signaling pathway decreases the Aβ peptide levels, due to a low β-secretase (BACE1) availability, since Wnt signaling activation repressed BACE1 transcription at the nuclear level (40, 41). The gene discussed is BACE1; the disease is Alzheimer disease.